+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Sickle cell disease: a continuing clinical and research dilemma: Bone marrow transplantation for sickle cell disease Walters, M.C. et al. (1996) New Engl. J. Med. 335, 369376 Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial Ferster, A. et al. (1996) Blood 88, 19601961



Sickle cell disease: a continuing clinical and research dilemma: Bone marrow transplantation for sickle cell disease Walters, M.C. et al. (1996) New Engl. J. Med. 335, 369376 Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial Ferster, A. et al. (1996) Blood 88, 19601961



Molecular Medicine Today 2(11): 450-451




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 062565160

Download citation: RISBibTeXText

DOI: 10.1016/1357-4310(96)85102-1


Related references

Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia. Pediatric Hematology and Oncology 16(3): 221-232, 1999

Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial. Blood 88(6): 1960-1964, 1996

Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Medicine 75(6): 300-326, 1996

Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood. Pediatric Blood and Cancer 65(9): E27228, 2018

Bone marrow and fat embolism in sickle cell anemia and sickle cell-hemoglobin C disease. Bulletin of the Johns Hopkins Hospital 103(1): 8-25, 1958

Clinical and laboratory factors associated with the severity of proliferative sickle cell retinopathy in patients with sickle cell hemoglobin C (SC) and homozygous sickle cell (SS) disease. Medicine 90(6): 372-378, 2012

Severe proliferative retinopathy is associated with blood hyperviscosity in sickle cell hemoglobin-C disease but not in sickle cell anemia. Clinical Hemorheology and Microcirculation 55(2): 205-212, 2014

Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 95(6): 1918-1924, 2000

Clinical complications in severe pediatric sickle cell disease and the impact of hydroxyurea. Pediatric Blood and Cancer 56(1): 90-94, 2010

Plasma lipids in Iranians with sickle cell disease: hypocholesterolemia in sickle cell anemia and increase of HDL-cholesterol in sickle cell trait. Clinica Chimica Acta; International Journal of Clinical Chemistry 365(1-2): 217-220, 2005

Sickle cell disease in Madhya Pradesh, Central India: A comparison of clinical profile of sickle cell homozygote vs. sickle-beta thalassaemia individuals. Hematology 21(9): 558-563, 2017

Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. The French Study Group on Sickle Cell Disease. Blood 91(12): 4472-4479, 1998

EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia. Jmir Research Protocols 5(3): E185, 2016

Studies in sickle-cell anemia. V. Sickle-cell hemoglobin C disease; report of two cases in siblings with clinical and genetic observations and a brief review of the literature. A.M.A. American Journal of Diseases of Children 90(1): 35-42, 1955

Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell Disease. Journal of Pediatric Hematology/Oncology 19(4): 313-318, 1997